期刊文献+

尿蛋白谱相关检测在特发性膜性肾病预后中的意义 被引量:10

Significance of detection of urinary protein spectrum in prognosis of idiopathic membranous nephropathy
原文传递
导出
摘要 目的探讨尿β2微球蛋白(β2-MG)、尿α1微球蛋白(α1-MG)、尿免疫球蛋白IgG、尿N-乙酰-β-D-葡萄糖苷酶(NAG)在特发性膜性肾病(IMN)患者预后的意义。方法选择2011年1月至2014年9月在新疆维吾尔自治区人民医院经临床及病理资料确诊的IMN患者60例,绘制受试者工作曲线(ROC),采用Cox风险比例模型进行单因素及多因素的预后影响因素分析,采用Kaplan-Meier曲线评估生存状况。结果 (1)IMN患者60例,其中男41例,女19例,男女之比为2.2∶1,主要表现为肾病综合征(76.7%),随访过程中,27例(45%)患者尿蛋白缓解。(2)绘制尿β2-MG、尿IgG、尿NAG及α1-MG的ROC曲线,其曲线下面积(AUC)分别为0.786、0.769、0.659和0.647,阈值分别为1.17 mg/L、24.98 mg/L、40.34 U/L和40.35 mg/L。行多因素分析得出尿β2-MG、尿IgG是影响预后的危险因素,P值分别为0.046和0.003,95%置信区间分别为1.105~1.137和1.015~1.076。结论 IMN以男性多见,部分患者可以发生尿蛋白缓解。尿β2-MG、尿IgG在对疾病的预后评估上有一定的价值,并且为影响肾功能下降的独立危险因素,对于高排出尿β2-MG、尿IgG的IMN患者应积极给予降尿蛋白治疗。 Objective To explore the prognostic value of urine beta 2 microglobulin (β2-MG), urine alpha 1 microglobulin (α1-MG), urine IgG, urinary N-acetyl-beta-D-glycosidase enzymes (NAG) in patients with idiopathic membranous nephropathy (IMN). Methods Sixty patients who were diagnosed for idiopathic membranous nephropathy by clinical or pathological data in People's Hospital of Xinjiang Uygur Autonomous Region from January 2011 to September 2014 were involved in this study. Receiver operating characteristic (ROC) curve was drew to determine the threshold. The Cox model was used to analyze the prognosis of influence factors, the survival rate of preset end point was assessed by Kaplan Meier curves. Results (1) Among 60 patients, there were 41 cases of men and 19 cases of women, the ratio of male and female was 2.2∶1, main clinical manifestation was nephrotic syndrome (76.7%). In the process of follow-up, urine protein of 27 cases (45%) was eased. (2) Areas under the curve (AUC) of β2-MG, IgG, NAG and α1-MG were 0.786, 0.769, 0.659 and 0.647, threshold values were 1.17 mg/L, 24.98 mg/L, 40.34 U/L and 40.35 mg/L. Line of multi-factor analysis showed that urine β2-MG and urine IgG had statistically significant, P values were 0.046 and 0.003, 95% confidence intervals were 1.105-1.137 and 1.015-1.076. Conclusion The patients with IMN were main for men, some patients can occur different degree of ease. β2-MG and urine IgG has a certain value on the evaluation of prognosis, and is also the independent risk factors of renal dysfunction, therefore, massive excretion of urine IgG and β2-MG of IMN should be given positive treatment.
出处 《中华临床医师杂志(电子版)》 CAS 2016年第5期631-635,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 新疆维吾尔自治区"十二五"重大科技专项(201230119) 国家自然科学基金课题(81560121)
关键词 肾小球肾炎 膜性 预后 尿蛋白 Membranous nephropathy,idiopathic Prognosis Urine protein
  • 相关文献

参考文献16

  • 1Haas M, Meehan SM, Karrison TG, et al. Changing etiologies ofunexplained adult nephrotic syndrome: a comparison of renal biopsyfindings from 1976-1979 and 1995-1997[J]. Am J Kidney Dis, 1997,30(5): 621-631.
  • 2Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (ChronicKidney Disease Epidemiology Collaboration). A new equation toestimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9):604-612.
  • 3Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1and PLA(2) R1 alleles in idiopathic membranous nephropathy[J]. NEngl J Med, 2011, 364(7): 616-626.
  • 4Lv JC, Hou WY, Zhou XJ. Interaction between PLA2R1 andHLA-DQA1 variants associates with anti-PLA2R antibodies andmembranous nephropathy[J]. J Am Soc Nephrol, 2013, 24(8):1323-1329.
  • 5Kim YG, Choi YW, Kim SY, et al. Anti-phospholipase A2 receptorantibody as prognostic indicator in idiopathic membranousnephropathy[J]. Am J Nephrol, 2015, 42(3): 250-257.
  • 6李坤.血、尿β2-微球蛋白在评价2型糖尿病患者肾脏早期损伤的应用价值[J].国际检验医学杂志,2007,28(9):854-854. 被引量:14
  • 7Hofstra JM, Deegens JK, Willems HL, et al. Beta-2-microglobulin issuperior to N-acetyl-beta-glucosaminidase in predicting prognosis inidiopathic membranous nephropathy[J]. Nephrol Dial Transplant,2008, 23(8): 2546-2551.
  • 8Bazzi C, Rizza V, Casellato D, et al. Fractional excretion of IgG inidiopathic membranous nephropathy with nephrotic syndrome: apredictive marker of risk and drug responsiveness[J]. BMC Nephrol,2014, 15: 74.
  • 9McQuarrie EP, Stirling CM, Geddes CC. Idiopathic membranousnephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy[J]. Nephrol Dial Transplant, 2012, 27(1):235-242.
  • 10Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors foridiopathic membranous nephropathy with nephrotic syndrome inJapan[J]. Kidney Int, 2004, 65(4): 1400-1407.

二级参考文献30

  • 1刘志红,黎磊石.积极应对继发性肾脏病带来的挑战[J].中华医学杂志,2004,84(21):1763-1764. 被引量:7
  • 2刘春凤,徐元钊,丁小强,傅辰生,张志刚,郭慕依.特发性膜性肾病预后影响因素[J].复旦学报(医学版),2005,32(2):192-196. 被引量:27
  • 3Hedinger MA. Structure, regulation and physiological role of urea transporters[J]. Kidney Int, 2001,49 : 1615.
  • 4Li LS,Liu ZH.Epidemiologic data of renal diseases from a single unit in China:analysis based on 13,519 renal biopsies.Kidney Int,2004,66(3):920-923.
  • 5Nangaku M,Shankland SJ,Couser WG.Cellular response to injury in membranous nephropathy.J Am Soc Nephrol,2005,16(5):1195-2004.
  • 6Ronco P,Debiec H.Molecular pathomechanisms of membranous nephropathy:from Heymann nephritis to alloimmunization.J Am Soc Nephrol,2005,16(5):1205-1213.
  • 7Cunningham PN,Quigg RJ.Contrasting roles of complement activation and its regulation in membranous nephropathy.J Am Soc Nephrol,2005,16(5):1214-1222.
  • 8Cattran D.Management of membranous nephropathy:when and what for treatment.J Am Soc Nephrol,2005,16(5):1188-1194.
  • 9Silva FG,D'Agativ,Nadasoly T.Renal biopsy interpretation,New York.Churchill Livingstone,1996,132-142.
  • 10Striker G,Striker LJ,D'Agati V.The renal Biopsy (third edition).Philadephia,Pennsylvania,W.B.Saudere Company,1997:60-69.

共引文献50

同被引文献85

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部